1 December 2005 in Telemedicine and e-Health
To develop and test a web-based Clinical Decision Support System (CDSS) tool, which integrated a new fuzzy multiple criteria classification methodology named PROAFTN in acute leukemia (AL) diagnosis. We have integrated a PROAFTN method and developed a web-based clinical decision support system using standard JSP, servlets, and XML technologies. All website data are database-driven; and the database system can handle data store, update, and retrieval instantly. Since the system was moved to a web server, we have started our experimental testing on 191 AL cases. The percentage of correct classification in this experimental testing was consistent with the proposed prototype. 96.4% of AL cases were correctly classified, proving that web-integration can be a promising tool for dissemination of CDSS tools. We found our system to be robust and capable of deployment for referring physicians. Our experimental results suggest that the Internet has promise as a means for distribution of CDSS tools. This system will help to: 1) make a "virtual" diagnosis and to compare its performances with given clinical diagnosis; 2) exchange health information between physicians and hematologists at the location and time of need; 3) assist online learning and simulate cases for training practitioners; 4) implement a strict security and access control for transmission of electronic health data through the Internet. The method will not replace specialists, but was developed to assist biologist-hematologists and general practitioners remotely in making decisions on medical diagnosis.
24 October 2026 in ACM Transactions on Computing for Healthcare
Psychiatric disorders affect millions, yet diagnosis depends on subjective assessments and uneven access to care. To address these challenges, there is a growing need for Contestable AI (CAI), a framework that extends beyond Explainable AI (XAI) by allowing clinicians to inspect, question, and revise algorithmic outputs, thereby reducing automation bias and strengthening accountability. We present Heart2Mind (Our implementation is available at: https://github.com/Analytics-Everywhere-Lab/heart2mind ), a human-centered CAI system for psychiatric disorder prediction that provides objective evidence while preserving clinical oversight. Heart2Mind collects R–R Interval (RRI) time series from Polar H9/H10 wearable ECG sensors via a Cardiac Monitoring Interface and analyzes them using a Multi-Scale Temporal-Frequency Transformer (MSTFT) that combines time-domain and frequency-domain features. For contestability, the Contestable Diagnosis Interface integrates model explanations with dialogue. Self-Adversarial Explanations compare attention-based and gradient-based explanation maps to flag inconsistent predictions, and a collaboration chatbot helps users verify and challenge outputs. On the HRV-ACC dataset, MSTFT achieved 91.7% accuracy under leave-one-out cross-validation, outperforming benchmark methods. Human-centered evaluation with the Human–CAI Consensus Rate showed experts and CAI could confirm correct decisions and correct errors through readable, efficient dialogues ( \(FKGL\approx 15\) , median 8.3 minutes, 4 turns). These results support low-cost wearable CAI screening with objective biomarkers, safeguards, and an interactive path for clinicians to refine recommendations.